SunLink Health Systems, Inc. (NYSE Amex Equities: SSY) today announced that Ron Turner, Senior Vice President and Chief Operating Officer, has been named to the additional role of Chief Development Officer. In his additional role, Mr. Turner will be responsible for the management of in-market growth and expansion opportunities, including the development of new services and the expansion of the company’s existing hospitals to better align them for future healthcare delivery. His new responsibilities will also encompass the acquisition of additional community hospitals and development of innovative partnerships with hospitals, physicians and other stakeholders. Mr. Turner will retain his role as Chief Operating Officer responsible for the operations of the company’s six existing hospitals, three nursing homes and a home health agency.
Mr. Thornton continued, “We are delighted to expand Ron Turner’s role which reflects SunLink’s commitment to the growth and expansion of its existing hospitals and its renewed position as an acquirer of community hospitals. Ron brings over 30 years’ of hospital management and leadership experience, including having been president of two hospital companies he started. His expertise in the acquisition, development and financing of community hospitals will be invaluable to SunLink’s renewed growth plans.”
SunLink Health Systems, Inc. currently operates six community hospitals and related nursing homes and a home care business in the Southeast and Midwest, and its specialty pharmacy business, SunLink Scripts Rx, in Louisiana and Georgia. Each SunLink hospital is the only hospital in its community. SunLink’s operating strategy is to link patients’ needs with dedicated physicians and health professionals to deliver quality, efficient medical care and healthcare products and services in each area it serves. For additional information on SunLink Health Systems, Inc., please visit the company’s website at
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts